Cancer screening rates far off target

Published: 27 January 2009 y., Tuesday

Gydytojas
In 2003, EU health ministers advised governments to put in place large-scale screening programmes for people at a higher risk of cancer because of generic factors like age and gender. Twenty-two countries have complied for breast cancer, 15 for cervical cancer and 12 for colorectal cancer. These common cancers can often be detected through relatively accurate and simple procedures like Pap smears and mammograms.

The ministers recommended carrying out some 125m cancer checks a year on people in the target groups. But a recent EU survey indicates that only about 51m screenings, or 41% of the desired number, are being performed. Of those, less than half are conducted in the recommended manner.

Together, breast, colorectal and cervical cancers account for one in three cancer deaths in women. For men, colorectal cancer accounts for 11% of cancer deaths. With the EU population ageing, those rates are set to increase unless preventive measures are taken.

Some 3.2m of 500m Europeans are diagnosed with cancer - the most common cause of death after circulatory disease. Breast cancer accounts for about 30% of cancer cases among women in the EU, far more than colorectal and cervical cancer with 13% and 3% respectively. In men, colorectal cancer accounts for 13% of cancer cases.

Cancer cases are distributed unevenly across the EU. Belgium has the highest incidence of breast cancer, but Denmark has the highest mortality rate. Romania has the lowest incidence and Spain the lowest mortality.

 

Šaltinis: ec.europa.eu
Copying, publishing, announcing any information from the News.lt portal without written permission of News.lt editorial office is prohibited.

Facebook Comments

New comment


Captcha

Associated articles

The most popular articles

NASA unveils new Mars exploration plan

NASA on Thursday unveiled an ambitious plan to send eight or more probes to Mars over the next two decades to search for evidence of water or life. more »

New multiple sclerosis drug OK’d

Cancer medication can be used for late-stage MS, says FDA more »

LATVIAN HIV RATE CONTINUES TO RISE

In September alone, 29 new HIV cases were registered in Latvia, making a total of 302 new cases this year, according to the AIDS Prevention Center. more »

Grim Harvest at Chernobyl

Wheat plants grown in soil from near the Chernobyl nuclear power plant have six times the rate of mutations as those grown in clean soil, according to a study in this week's issue of Nature. more »

Fat 'is an organ' say scientists

Scientists believe fat plays an important role in helping the body to work properly. more »

Cos. Give Discounts on Health Care

A rise in both the number of uninsured and out-of-pocket medical expenses has spurred several companies to form discount clubs that offer savings on prescription drugs, doctor visits and other medical services. more »

Estonian country-wide gene banks

Estonia will soon begin setting up one of the world's first country-wide gene banks where the detailed genetic codes of two-thirds of the population will be stored. more »

North Pole: Ice Turns to Water

For the first time in 50 million years, visitors to the North Pole can see something extraordinary: water. more »

Single-Dose Drug Is Approved For ADHD

The first single-dose form of the drug most widely used to treat attention deficit disorder in children won U.S. government approval yesterday. more »

Study Examines Internet Sex Risks

People who use the Internet to find real-life sex partners are more likely to have had sexually transmitted diseases or engaged in risky intimate behavior, a government-led study found. more »